Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy(HAIC) Combined with PD-1 Inhibitors for Advanced ...
Introduction As the third leading cause of cancer-related deaths globally, hepatocellular carcinoma(HCC) exhibits significant heterogeneity based on its biological characteristics, leading to varying sensitivities to different treatment approaches.1–3 …